Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on DAG. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN103804266A offers a streamlined route for vildagliptin intermediates. Reduces costs and improves supply chain reliability for global pharmaceutical manufacturers.
Novel phase-transfer catalysis method enhances Vildagliptin purity and yield. Offers significant cost reduction in API manufacturing and supply chain reliability for global partners.
Novel amide solvent method enhances purity and yield for Vildagliptin manufacturing, offering significant supply chain stability and cost reduction benefits.
Patent CN102617434B details a novel one-pot method for Vildagliptin. This process reduces purification steps and enhances yield for cost-effective manufacturing.